Approval · Notice of Compliance 20615 · 2018
EYLEA: Notice of Compliance 20615
Issued March 9, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20615
- Date
- March 9, 2018
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate dosing schedule
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EYLEA | Not yet assigned | — |
Medicinal ingredients
- AFLIBERCEPT 40 MG per ML